Clinical Trial Detail

NCT ID NCT03573024
Title Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Colorado, Denver
Indications

acute myeloid leukemia

Therapies

Venetoclax

Azacitidine

Age Groups: adult

No variant requirements are available.